Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance he has issued to NHS hospital, community and mental health trusts on (a) recognising and (b) managing the risk that prescribed insulin poses to patients with a dual diagnosis of Type 1 Diabetes and an eating disorder; and if he will make a statement.
Answered by Gillian Keegan - Secretary of State for Education
NHS England and NHS Improvement’s ‘Adult Eating Disorders: Community, Inpatient and Intensive Day Patient Care – Guidance for commissioners and providers’, published in August 2019, guidance on managing comorbid conditions including diabetes. NHS England and NHS Improvement have developed two pilot services to test, trial and evaluate the effects of integrated diabetes and mental health pathways for the identification, assessment and treatment of patients with type 1 diabetes and disordered eating in London and the South. The draft evaluation for the pilots found that a means of increasing awareness among healthcare professionals of the risks for those who have type 1 diabetes and an eating disorder, should be developed to aid identification and diagnosis.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to answer Question 79292, tabled by the hon. Member for Broxbourne on 22 November 2021, regarding coronavirus and vaccination.
Answered by Edward Argar - Minister of State (Ministry of Justice)
I refer the hon. Member to the answer to Question 79292.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he expects the MHRA to license a covid-19 nasal vaccine; and whether approval of nasal vaccines will be fast-tracked in line with injectable covid-19 vaccines; and if he will make a statement.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Any route to approval of nasal vaccine treatments is subject to the developer seeking regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA is therefore unable to provide a timetable for the approval of a COVID-19 nasal vaccine, as information on products not approved for use in the United Kingdom is commercially and market-sensitive. As with all other COVID-19 vaccines, the MHRA will ensure a thorough and expedited assessment of any such medicine’s safety and efficacy before any authorisation.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if the Government will make an assessment of the potential merits of providing financial compensation to UK citizens who were required to quarantine in hotels for the period starting at 4:00am on 28 November 2021; and if he will make a statement.
Answered by Maggie Throup
We have no plans to make this assessment. There are no refunds or financial compensation available for guests who completed their quarantine period and had checked out of the managed quarantine hotel on or before 4am on 15 December. From 4pm on 15 December, guests with a negative polymerase chain reaction (PCR) test result and those who had not yet taken a PCR test were able to depart the quarantine hotel. In England, guests who were released early from managed quarantine are entitled to a refund for the unused part of their stay.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what measures are in place to ensure that people who have received the covid-19 booster injection have their vaccine status updated on their NHS electronic record; and if he will make a statement.
Answered by Maggie Throup
All COVID-19 vaccinations, including boosters, administered by NHS England show on an individual’s National Health Service electronic record. Events are recorded in approved COVID-19 Point-of-Care applications. The data of the vaccination events is then shared back into the citizen's medical record.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Local Authority Services and National Health Service Complaints (England) Regulations 2009 allow for two separate complaints, made by a patient, on the delivery of NHS care and treatment to be investigated concurrently by the relevant professional bodies of qualified healthcare staff; and if will make a statement.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Local Authority Social Services and National Health Service Complaints (England) Regulations 2009 do allow for two separate complaints made by a patient to be investigated concurrently. There is nothing in the regulations that would prevent this from taking place.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 20 October 2021 to Question 56847, on the WHO Framework Convention on Tobacco Control, if he will provide the details of the people comprising the UK delegation at the WHO Framework Convention on Tobacco Control COP9.
Answered by Maggie Throup
The Deputy Director for Addictions and Inclusion Policy for the Office for Health Improvement and Disparities will lead the delegation COP9, supported by members of the Tobacco Control team and support from the United Kingdom Mission in Geneva.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans the Government has to recognise covid-19 vaccines administered to UK nationals who are living or resident overseas; and if he will make statement.
Answered by Maggie Throup
Individuals, including United Kingdom nationals living overseas, vaccinated in over 100 countries and territories who have had a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body are now recognised in the same way as returning fully vaccinated UK residents if they have not visited a ‘red list’ country or territory in the 10 days before arriving in England. We continue to work to expand the list of countries and territories whose vaccine certificates are recognised.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the report of the Independent Medicines and Medical Devices Safety Review entitled First Do No Harm, what steps the Government is taking to help ensure greater transparency of the reporting of research and sponsorship payments made by medical device manufacturers to (a) doctors, (b) teaching hospitals, (c) research institutions and (d) charities; and if he will make a statement.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government’s response to the Independent Medicines and Medical Devices Safety Review was published on 26 July 2021. The Government accepted in principle the recommendation on the ‘mandatory reporting for the pharmaceutical and medical device industries of payments made to teaching hospitals, research institutions and individual clinicians'. The Department is exploring options in relation to expanding and reinforcing current industry schemes and making reporting mandatory through legislation. We aim to publish an update on progress in summer 2022.
Asked by: Charles Walker (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether provision is being made for observers, outside the national delegations, to attend the Ninth Session of the Conference of the Parties (COP9) to the WHO Framework Convention on Tobacco Control.
Answered by Maggie Throup
The Department has no plans to provide a submission to the Ninth Session of the Conference of the Parties' secretariat ahead of the Conference. The Deputy Director for Addictions and Inclusion Policy at the Office for Health Improvement and Disparities will lead the United Kingdom delegation with support from officials at the UK Mission in Geneva.
Applications to attend as an observer are a matter for the Conference secretariat and consequently, we are not aware of exclusions of third party representatives.